DexCom Inc. Files Q3 2024 10-Q
Ticker: DXCM · Form: 10-Q · Filed: 2024-10-24T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
Related Tickers: DXCM
TL;DR
DexCom's Q3 2024 10-Q is in, showing their latest financials. #DXCM
AI Summary
DexCom Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter of 2024. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the medical device sector.
Why It Matters
This filing provides investors and analysts with the latest financial health and operational performance of DexCom, a key player in diabetes management technology.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing (10-Q) and does not inherently introduce new risks beyond those already associated with the company's business.
Key Players & Entities
- DexCom Inc. (company) — Filer of the 10-Q
- 20240930 (date) — End of the reporting period
- 20241024 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on October 24, 2024.
What is DexCom Inc.'s Standard Industrial Classification code?
DexCom Inc.'s Standard Industrial Classification code is 3841, for Surgical & Medical Instruments & Apparatus.
What is the company's state of incorporation?
DexCom Inc. is incorporated in Delaware (DE).
What is the company's primary business address?
The company's business address is 6340 Sequence Drive, San Diego, CA 92121.
From the Filing
0001093557-24-000180.txt : 20241024 0001093557-24-000180.hdr.sgml : 20241024 20241024171302 ACCESSION NUMBER: 0001093557-24-000180 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241024 DATE AS OF CHANGE: 20241024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 241393439 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 10-Q 1 dxcm-20240930.htm 10-Q dxcm-20240930 false 2024 Q3 0001093557 12/31 0.0243476 0.0061571 0.006662 365 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure dxcm:purchaser utr:D dxcm:segment dxcm:primary_market 0001093557 2024-01-01 2024-09-30 0001093557 2024-10-17 0001093557 2024-09-30 0001093557 2023-12-31 0001093557 2024-07-01 2024-09-30 0001093557 2023-07-01 2023-09-30 0001093557 2023-01-01 2023-09-30 0001093557 us-gaap:CommonStockMember 2024-06-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001093557 us-gaap:RetainedEarningsMember 2024-06-30 0001093557 us-gaap:TreasuryStockCommonMember 2024-06-30 0001093557 2024-06-30 0001093557 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001093557 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0001093557 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001093557 us-gaap:CommonStockMember 2024-09-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001093557 us-gaap:RetainedEarningsMember 2024-09-30 0001093557 us-gaap:TreasuryStockCommonMember 2024-09-30 0001093557 us-gaap:CommonStockMember 2023-06-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001093557 us-gaap:RetainedEarningsMember 2023-06-30 0001093557 us-gaap:TreasuryStockCommonMember 2023-06-30 0001093557 2023-06-30 0001093557 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001093557 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0001093557 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001093557 us-gaap:CommonStockMember 2023-09-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001093557 us-gaap:RetainedEarningsMember 2023-09-30 0001093557 us-gaap:TreasuryStockCommonMember 2023-09-30 0001093557 2023-09-30 0001093557 us-gaap:CommonStockMember 2023-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001093557 us-gaap:RetainedEarningsMember 2023-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2023-12-31 0001093557 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001093557 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-09-30 0001093557 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0001093557 us-gaap:CommonStockMember 2022-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncom